The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, awarded a single-award Indefinite Delivery Contract valued up to $146,300,000 to Southern Research Institute, a non-profit research organization, to develop and employ animal and animal replacement models of infectious diseases. The contract will support screening, product evaluation, and eventual clinical evaluation of vaccines, therapeutics, and...
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a single-award, $146.3 million Indefinite Delivery Contract (IDC) to The Research Foundation For The State University Of New York to develop and employ animal and animal replacement models of infectious diseases for screening, product evaluation, and eventual clinical evaluation. This IDC contains four task areas: Task Area A - Small Animal Models of Infectious Diseases Task Area B - Non-Human Primate Models of...
This indefinite delivery contract with the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, aims to provide preclinical models of infectious diseases to support the development and evaluation of medical countermeasures. The single award contract, valued at up to $146.3 million, has a 7-year ordering period and covers three task areas: Task Area A - Small Animal Models of Infectious Diseases Task Area B - Non-Human Primate Models of Infectious Diseases Task Area C...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a single-award Indefinite Delivery Contract (IDC) worth up to $146,300,000 to The Johns Hopkins University to provide pre-clinical models of infectious diseases. The contract has a period of performance from July 2024 to July 2031. The contract encompasses four task areas: (A) Small Animal Models, (B) Non-Human Primate Models, (C) Animal Replacement and Non-Traditional Animal Models, and (D) Generation and Distribution...
This single-award Indefinite Delivery Contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Battelle Memorial Institute, a non-profit organization and manufacturer of goods, to provide pre-clinical models of infectious diseases. The $146.3 million, 7-year contract has a completion date of July 14, 2031 and was awarded on July 15, 2024. The contract aims to develop and employ animal and...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to the American Foundation For Biological Research, doing business as the Biomedical Research Institute. The $146.3 million single-award IDC has a period of performance from July 15, 2024 to July 14, 2031. The purpose of this IDC is to provide NIAID with the capability and capacity to develop and employ...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to The Charles Stark Draper Laboratory, Inc. (Draper) for the development and employment of animal and animal replacement models of infectious diseases. The $146.3 million single-award IDC has a 7-year ordering period and supports the full range of preclinical evaluations, including screening, product evaluation, and eventual clinical evaluation of...
The federal contract IDV award, with an ID of 75N93024D00022, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS). This single-award Indefinite Delivery Contract, potentially valued up to $146,300,000, is for pre-clinical models of infectious diseases under task areas A, B, and C. The prime contractor, Texas Biomedical Research Institute, will provide a range of services including developing...
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a $146.3 million single-award Indefinite Delivery Contract (IDC) to the UK Health Security Agency (formerly Public Health England) to provide preclinical services in support of the development of medical countermeasures against chemical, biological, radiological, and nuclear threats. The contract includes task areas for small animal models, non-human primate models, animal replacement and non-traditional animal models,...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, has awarded a $146,300,000 single-award Indefinite Delivery Contract (IDC) to the University of Pittsburgh for the "Pre-Clinical Models of Infectious Diseases - Task Areas A and B" program. The contract has a period of performance through July 2031. The IDC aims to provide NIAID with the capability and capacity to develop and employ animal and animal replacement models of infectious diseases for...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. Department of Health and Human Services, awarded a $146.3 million Indefinite Delivery Contract (IDC) to Institute For Clinical Pharmacodynamics, Inc., a for-profit organization, to provide pre-clinical models of infectious diseases under Task Area C. The period of performance is from July 15, 2024 to July 14, 2031.
The contract is a follow-on to a previous Preclinical Models of Infectious Diseases IDIQ program, and aims to support the development and refinement of animal and animal replacement models to evaluate the efficacy of candidate countermeasures (vaccines, therapeutics, diagnostics) against a range of infectious agents, including RNA viruses with pandemic potential, antimicrobial resistant infections, and diseases caused by pathogens on the NIAID Emerging Infectious Diseases/Pathogens list. The contractor will be responsible for animal model studies, pathogen production and characterization, and other related services. No set-aside was used for this multiple award contract.